Vitality Watch

Dossier clinicaltrials trial early 21-jul-2026
Small or early-phase human trial or pilot study

Promoting Cognitive Resilience and Reducing Frailty in Older Veterans With Bright Light Therapy

Key claim: A pilot randomized trial will test whether home-based bright light therapy is feasible and can improve frailty, cognition, and sleep in older Veterans via circadian resynchronization.

Abstract

Frailty is a multifactorial syndrome characterized by vulnerability to stressors that is intricately linked to cognitive impairment and mortality risk. Bright light therapy (BLT) reduces circadian disturbances by resynchronizing the hypothalamic biological clock via specific wavelengths of light. Human trials have demonstrated that BLT improves sleep quality and cognitive function in older adults. However, BLT has not been examined for use in older Veteran populations, particularly the impact on frailty. This randomized trial will assess the feasibility of employing BLT to study impacts on frailty, cognition, and sleep in older Veterans. Findings from this pilot will establish the power and effect size necessary for larger trials to support the use of BLT as readily available home-based treatment to improve healthspan of Veterans.

Why this matters

A pilot randomized trial will test whether home-based bright light therapy is feasible and can improve frailty, cognition, and sleep in older Veterans via circadian resynchronization.

Source

Link

Briefing card

Promoting Cognitive Resilience and Reducing Frailty in Older Veterans With Bright Light Therapy
Stage: trial early · clinicaltrials · 21-jul-2026

A pilot randomized trial will test whether home-based bright light therapy is feasible and can improve frailty, cognition, and sleep in older Veterans via circadian resynchronization.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05631236

build build 880 · 2bcef25 · 2026-11-18